Curcumin in Alzheimer’s disease: Can we think to new strategies and perspectives for this molecule?

2016, Alzheimer's Association. Alzheimer's disease facts and figures, Alzheimers Dement, 12, 459 Walsh, 2004, Deciphering the molecular basis of memory failure in Alzheimer's disease, Neuron, 44, 181, 10.1016/j.neuron.2004.09.010 Cummings, 2004, Treatment of Alzheimer's disease: current and future therapeutic approaches, Rev. Neurol. Dis., 1, 60 Schneider, 2014, Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014, J. Intern. Med., 275, 251, 10.1111/joim.12191 Kim, 2013, Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model, Neurobiol. Aging, 34, 2408, 10.1016/j.neurobiolaging.2013.03.029 Wisniewski, 2010, Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models, Brain Struct. Funct., 214, 201, 10.1007/s00429-009-0236-2 Wisniewski, 2015, Immunotherapeutic approaches for Alzheimer's disease, Neuron, 85, 1162, 10.1016/j.neuron.2014.12.064 Jiang, 2017, Curcumin as a potential protective compound against cardiac diseases, Pharmacol. Res., 119, 373, 10.1016/j.phrs.2017.03.001 Lelli, 2017, Curcumin use in pulmonary diseases: state of the art and future perspectives, Pharmacol. Res., 115, 133, 10.1016/j.phrs.2016.11.017 Fadus, 2016, Curcumin An age-old anti-inflammatory and anti-neoplastic agent, J. Tradit. Complement. Med., 7, 339 Ammon, 1991, Pharmacology of curcuma longa, Planta Med., 57, 1, 10.1055/s-2006-960004 Ahmed, 2014, Therapeutic potential of turmeric in Alzheimer's disease: curcumin or curcuminoids?, Phytother. Res., 28, 517, 10.1002/ptr.5030 Ahmed, 2009, Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease, Pharmacol. Biochem. Behav., 91, 554, 10.1016/j.pbb.2008.09.010 Park, 2002, Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease, J. Nat. Prod., 65, 1227, 10.1021/np010039x Kim, 2001, Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1–42) insult, Neurosci. Lett., 303, 57, 10.1016/S0304-3940(01)01677-9 Kim, 2005, Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid, J. Agric. Food Chem., 53, 8537, 10.1021/jf051985c Shi, 2015, Curcumin inhibits Aβ-induced microglial inflammatory responses in vitro: involvement of ERK1/2 and p38 signaling pathways, Neurosci. Lett., 6, 105, 10.1016/j.neulet.2015.03.045 Cianciulli, 2016, PI3k/Akt signalling pathway plays a crucial role in the anti-inflammatory effects of curcumin in LPS-activated microglia, Int. Immunopharmacol., 36, 282, 10.1016/j.intimp.2016.05.007 Liu, 2016, Curcumin attenuates beta-Amyloid-Induced neuroinflammation via activation of peroxisome proliferator-Activated receptor-Gamma function in a rat model of alzheimer's disease, Front. Pharmacol., 19, 261 Sahebkar, 2016, Curcumin downregulates human tumor necrosis factor-α levels: a systematic review and meta-analysis ofrandomized controlled trials, Pharmacol. Res., 107, 234, 10.1016/j.phrs.2016.03.026 Derosa, 2016, Effect of curcumin on circulating interleukin-6 concentrations: a systematic review and meta-analysis of randomized controlled trials, Pharmacol. Res., 111, 394, 10.1016/j.phrs.2016.07.004 Gibellini, 2015, Pinti M. natural compounds modulating mitochondrial functions, Evid. Based Complement. Alternat. Med., 10.1155/2015/527209 Uğuz, 2016, Curcumin inhibits apoptosis by regulating intracellular calcium release, reactive oxygen species and mitochondrial depolarization levels in SH-SY5Y neuronal cells, J. Recept. Signal Transduct. Res., 36, 395, 10.3109/10799893.2015.1108337 Fan, 2017, Reversal of beta-Amyloid-Induced neurotoxicity in PC12Cells by curcumin, the important role of ROS-Mediated signaling and ERK pathway, Cell. Mol. Neurobiol., 37, 211, 10.1007/s10571-016-0362-3 Ono, 2004, Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro, J. Neurosci. Res., 75, 742, 10.1002/jnr.20025 Zhang, 2006, Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients, J. Alzheimers Dis., 10, 1, 10.3233/JAD-2006-10101 Shimmyo, 2008, Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation, Neuroreport, 19, 1329, 10.1097/WNR.0b013e32830b8ae1 Garcia-Alloza, 2007, Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model, J. Neurochem., 102, 1095, 10.1111/j.1471-4159.2007.04613.x Wang, 2009, Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse, Neurotox. Res., 15, 3, 10.1007/s12640-009-9000-x Goozee, 2016, Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease, Br. J. Nutr., 115, 449, 10.1017/S0007114515004687 Tang, 2017, The mechanisms of action of curcumin in alzheimer's disease, J. Alzheimers Dis. Patil, 2015, Polymalic acid-Based MRI contrast agent for the detection of Aβ plaques in alzheimer's disease, Macromol. Biosci., 15, 1212, 10.1002/mabi.201500062 Brondino, 2014, Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies, Sci. World J., 174282 Nelson, 2017, The essential medicinal chemistry of curcumin, J. Med. Chem., 60, 1620, 10.1021/acs.jmedchem.6b00975 Anand, 2007, Bioavailability of curcumin: problems and promises, Mol. Pharm., 4, 807, 10.1021/mp700113r Srinivasan, 2007, Black pepper and its pungent principle-piperine: a review of diverse physiological effects, Crit. Rev. Food Sci. Nutr., 47, 735, 10.1080/10408390601062054 Chonpathompikunlert, 2010, Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease, Food Chem. Toxicol., 48, 798, 10.1016/j.fct.2009.12.009 Parachikova, 2010, Formulation of a medical food cocktail for Alzheimer's disease: beneficial effects on cognition and neuropathology in a mouse model of the disease, PLoS One, 5, e14015, 10.1371/journal.pone.0014015 Suresh, 2010, Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats, Indian J. Med. Res., 131, 682 Antony, 2008, A pilot cross-Over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin, Indian J. Pharm. Sci., 70, 445, 10.4103/0250-474X.44591 Cuomo, 2011, Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation, J. Nat. Prod., 74, 664, 10.1021/np1007262 Jäger, 2014, Comparative absorption of curcumin formulations, Nutr. J., 13 Sasaki, 2011, Innovative preparation of curcumin for improved oral bioavailability, Biol. Pharm. Bull., 34, 660, 10.1248/bpb.34.660 Sunagawa, 2015, Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study, J. Nutr. Sci. Vitaminol. (Tokyo), 61, 37, 10.3177/jnsv.61.37 Tsai, 2011, Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration, Int. J. Pharm., 416, 331, 10.1016/j.ijpharm.2011.06.030 Doggui, 2012, Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line, J. Alzheimers Dis., 30, 377, 10.3233/JAD-2012-112141 Ray, 2011, Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease, J. Alzheimers Dis., 23, 61, 10.3233/JAD-2010-101374 Chiang, 2017, Relationships among cortical glutathione levels, brain amyloidosis, and memory in healthy older adults investigated In vivo with 1H-MRS and Pittsburgh compound-B PET, AJNR Am. J. Neuroradiol., 38, 1130, 10.3174/ajnr.A5143 Biswas, 2014, An amyloid inhibitor octapeptide forms amyloid type fibrous aggregates and affects microtubule motility, Chem. Commun. (Camb), 50, 2604, 10.1039/C3CC49396B Adak, 2017, Biodegradable neuro-Compatible peptide hydrogel promotes neurite outgrowth, shows significant neuroprotection, and delivers anti-Alzheimer drug, ACS Appl. Mater. Interfaces, 9, 5067, 10.1021/acsami.6b12114 Uliassi, 2017, Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery, Future Med. Chem., 9, 995, 10.4155/fmc-2017-0038 Tiwari, 2014, Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer’s disease model via canonical Wnt/b-catenin pathway, ACS Nano, 8, 76, 10.1021/nn405077y Liu, 2014, Effects of curcumin on learning and memory deficits, BDNF, and ERK protein expression in rats exposed to chronic unpredictable stress, Behav. Brain Res., 116, 10.1016/j.bbr.2014.05.068 Zhang, 2015, Curcumin improves amyloid (-Peptide (1–42) induced spatial memory deficits through BDNF-ERK signaling pathway, PLoS One, 10, e0131525, 10.1371/journal.pone.0131525 Bora-Tatar, 2014, Investigations of curcumin and resveratrol on neurite outgrowth: perspectives on spinal muscular atrophy, Biomed. Res. Int., 10.1155/2014/709108 Dikmen, 2017, Comparison of the effects of curcumin and RG108 on NGF-Induced PC-12 adh cell differentiation and neurite outgrowth, J. Med. Food, 20, 376, 10.1089/jmf.2016.3889 Kuo, 2015, Rescuing apoptotic neurons in Alzheimer's disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin, Int. J. Nanomed., 1, 2653, 10.2147/IJN.S79528 Liu, 2005, A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting, Neurobiol. Dis., 19, 407, 10.1016/j.nbd.2005.01.022 Park, 2007, Neuron-specific delivery of nucleic acids mediated by Tet1-modified poly(ethylenimine), J. Gene Med., 9, 691, 10.1002/jgm.1062 Mathew, 2012, Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease, PLoS One, 7, 10.1371/journal.pone.0032616 Mulik, 2010, ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model, Mol. Pharm., 7, 815, 10.1021/mp900306x Martel, 1997, Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta, J. Neurochem., 69, 1995 Airoldi, 2011, Curcumin derivatives as new ligands of Aβ peptides, J. Biotechnol., 156, 317, 10.1016/j.jbiotec.2011.07.021 Conti, 2017, Multifunctional liposomes interact with Abeta in human biological fluids: therapeutic implications for Alzheimer's disease, Neurochem. Int. Taylor, 2011, Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide, Nanomedicine, 7, 541, 10.1016/j.nano.2011.06.015 Mourtas, 2011, Curcumin-decorated nanoliposomes with very high affinity for amyloid-(1–42 peptide, Biomaterials, 32, 1635, 10.1016/j.biomaterials.2010.10.027 Markoutsa, 2011, Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line, Eur. J. Pharm. Biopharm., 77, 265, 10.1016/j.ejpb.2010.11.015 Papadia, 2017, Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept, Eur. J. Pharm. Sci., 101, 140, 10.1016/j.ejps.2017.02.019 Papadia, 2017, Multifunctional LUV liposomes decorated for BBB and amyloid targeting − B. In vivo brain targeting potential in wild-type and APP/PS1 mice, Eur. J. Pharm. Sci., 102, 180, 10.1016/j.ejps.2017.03.010 Le Droumaguet, 2012, Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease, ACS Nano, 6, 5866, 10.1021/nn3004372 Storka, 2015, Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans, Int. J. Clin. Pharmacol. Ther., 53, 54, 10.5414/CP202076 McClure, 2017, Aerosol delivery of curcumin reduced amyloid-β deposition and improved cognitive performance in a transgenic model of alzheimer's disease, J. Alzheimers Dis., 55, 797, 10.3233/JAD-160289 Rosini, 2016, Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics, Future Med. Chem., 8, 697, 10.4155/fmc-2016-0003 Rosini, 2014, Polypharmacology: the rise of multitarget drugs over combination therapies, Future Med. Chem., 6, 485, 10.4155/fmc.14.25 Bottegoni, 2012, The role of fragment-based and computational methods in polypharmacology, Drug Discov. Today, 17, 23, 10.1016/j.drudis.2011.08.002 Weinreb, 2016, Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and (-amyloid in ageing and Alzheimer's disease, Br. J. Pharmacol., 173, 2080, 10.1111/bph.13318 Rosini, 2014, Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces, Neurochem. Res., 39, 1914, 10.1007/s11064-014-1250-1 Pévet, 2000, Melatonin and biological rhythms, Biol. Signals Recept., 9, 203, 10.1159/000014640 Zhou, 2003, Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels, J. Pineal Res., 35, 125, 10.1034/j.1600-079X.2003.00065.x Hatfield, 2004, Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia, Brain, 127, 1061, 10.1093/brain/awh129 Chojnacki, 2014, Discovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatonin, ACS Chem. Neurosci., 20, 690, 10.1021/cn500081s Esatbeyoglu, 2012, Curcumin?from molecule to biological function, Angew. Chem. Int. Ed. Engl., 22, 5308, 10.1002/anie.201107724 Rosales-Corral, 2012, Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin, J. Pineal Res., 52, 167, 10.1111/j.1600-079X.2011.00937.x Sopher, 1996, Neurodegenerative mechanisms in Alzheimer disease. A role for oxidative damage in amyloid beta protein precursor-mediated cell death, Mol. Chem. Neuropathol., 29, 153, 10.1007/BF02814999 Gerenu, 2015, Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model, ACS Chem. Neurosci., 6, 1393, 10.1021/acschemneuro.5b00082 Liu, 2017, Design, synthesis and biological evaluation of multifunctional tacrine-curcumin hybrids as new cholinesterase inhibitors with metal ions-chelating and neuroprotective property, Bioorg. Med. Chem., 25, 2387, 10.1016/j.bmc.2017.02.049 Banerjee, 2015, Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity, Acc. Chem. Res., 48, 2075, 10.1021/acs.accounts.5b00127 Zatta, 2009, Alzheimer's disease, metal ions and metal homeostatic therapy, Trends Pharmacol. Sci., 30, 346, 10.1016/j.tips.2009.05.002 Yan, 2017, Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin, Bioorg. Med. Chem., 25, 2946, 10.1016/j.bmc.2017.02.048 Mohamed, 2012, One-pot three-component synthesis of novel heterocyclic steroids as a central antioxidant and anti-inflammatory agents, Steroids, 77, 1469, 10.1016/j.steroids.2012.09.001 Elmegeed, 2015, Synthesis of novel steroidal curcumin derivatives as anti-Alzheimer's disease candidates: evidences-based on in vivo study, Steroids, 101, 78, 10.1016/j.steroids.2015.06.003 Lenhart, 2010, Clicked bivalent ligands containing curcumin and cholesterol as multifunctional abeta oligomerization inhibitors: design, synthesis, and biological characterization, J. Med. Chem., 53, 6198, 10.1021/jm100601q Liu, 2012, Bivalent ligands targeting multiple pathological factors involved in Alzheimer's disease, ACS Med. Chem. Lett., 3, 942, 10.1021/ml300229y Simoni, 2010, Polyamine conjugation of curcumin analogues toward the discovery of mitochondria-directed neuroprotective agents, J. Med. Chem., 53, 7264, 10.1021/jm100637k Simoni, 2016, Polyamine conjugation as a promising strategy to target amyloid aggregation in the framework of alzheimer's disease, ACS Med. Chem. Lett., 7, 1145, 10.1021/acsmedchemlett.6b00339 Pocernich, 2011, Nutritional approaches to modulate oxidative stress in Alzheimer's disease, Curr. Alzheimer Res., 8, 452, 10.2174/156720511796391908 Stefani, 2013, Protein folding and aggregation into amyloid: the interference by natural phenolic compounds, Int. J. Mol. Sci., 14, 12411, 10.3390/ijms140612411 Simoni, 2016, Nature-Inspired multifunctional ligands: focusing on amyloid-Based molecular mechanisms of alzheimer's disease, ChemMedChem, 11, 1309, 10.1002/cmdc.201500422 Simoni, 2017, Targeting the nrf2/Amyloid-Beta liaison in alzheimer's disease: a rational approach, ACS Chem. Neurosci. Kim, 2014, Keap1 cysteine 288 as a potential target for diallyl trisulfide-induced Nrf2 activation, PLoS One, 9, e85984, 10.1371/journal.pone.0085984 Burgos-Morón, 2010, The dark side of curcumin, Int. J. Cancer, 126, 1771 Roskoski, 2017, Guidelines for preparing color figures for everyone including the colorblind, Pharmacol. Res., 119, 240, 10.1016/j.phrs.2017.02.005